Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shukuan Li

Showing results (11-20 of 56) with videos related to

Pageof 6
Sort By:
Cells|May 5, 2019
Efficacy of Recombinant Methioninase (rMETase) on Recalcitrant Cancer Patient-Derived Orthotopic Xenograft (PDOX) Mouse Models: A ReviewKei Kawaguchi, Qinghong Han, Shukuan Li, et al.
Anticancer Research|April 28, 2026
Sulfasalazine an Inhibitor of System x<sub>C</sub> <sup>-</sup> (Cystine/glutamate Antiporter), Combined With Recombinant Methioninase, Inhibits Both Cancer and Normal Cells, Suggesting Lack of Cancer Selectivity of Cysteine RestrictionJinsoo Kim, Qinghong Han, Shukuan Li, et al.
Frontiers in Oncology|June 19, 2026
Direct comparison of efficacy of combining ivermectin versus five first-line chemotherapy drugs with recombinant methioninase against colon-cancer cellsJinsoo Kim, Qinghong Han, Shukuan Li, et al.
Anticancer Research|June 27, 2025
The Conditions of Non-rescuability of Methioninase-treated Cancer Cells by Methionine Replenishment: The Point of No ReturnByung Mo Kang, Qinghong Han, Shukuan Li, et al.
Cell Cycle (Georgetown, Tex.)|May 7, 2016
Tumor-specific cell-cycle decoy by Salmonella typhimurium A1-R combined with tumor-selective cell-cycle trap by methioninase overcome tumor intrinsic chemoresistance as visualized by FUCCI imagingShuya Yano, Kiyoto Takehara, Ming Zhao, et al.
Methods in Molecular Biology (Clifton, N.J.)|February 7, 2019
Development of Recombinant Methioninase for Cancer TreatmentRobert M Hoffman, Yuying Tan, Shukuan Li, et al.
Anticancer Research|January 30, 2026
Lack of Cancer Specificity of Methionine Adenosyltransferase 2A (MAT2A) Inhibitor AG-270 in Combination With Recombinant Methioninase <i>In Vitro</i>Jinsoo Kim, Qinghong Han, Shukuan Li, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 13, 2005
Tumor-targeting bacterial therapy with amino acid auxotrophs of GFP-expressing Salmonella typhimuriumMing Zhao, Meng Yang, Xiao-Ming Li, et al.
Anticancer Research|December 30, 2025
Effect of Recombinant Methioninase Dose and Timing on the Selective and Precise Elimination of Cancer Cells from Co-Cultured Normal Cells and on Methionine-dependent Rescue of Cancer CellsJinsoo Kim, Qinghong Han, Shukuan Li, et al.
Anticancer Research|October 28, 2025
Simultaneous Targeting of Multiple Hallmarks of Cancer With Recombinant Methioninase, Rapamycin and Chloroquine Is Specific and Synergistic to MiaPaCa-2 Pancreatic-Cancer Cells in Contrast to Hs-27 Normal FibroblastsJinsoo Kim, Qinghong Han, Shukuan Li, et al.
Pageof 6

Showing results (11-20 of 56) with videos related to

Sort By:
Pageof 6
Cells|May 5, 2019
Efficacy of Recombinant Methioninase (rMETase) on Recalcitrant Cancer Patient-Derived Orthotopic Xenograft (PDOX) Mouse Models: A ReviewKei Kawaguchi, Qinghong Han, Shukuan Li, et al.
Anticancer Research|April 28, 2026
Sulfasalazine an Inhibitor of System x<sub>C</sub> <sup>-</sup> (Cystine/glutamate Antiporter), Combined With Recombinant Methioninase, Inhibits Both Cancer and Normal Cells, Suggesting Lack of Cancer Selectivity of Cysteine RestrictionJinsoo Kim, Qinghong Han, Shukuan Li, et al.
Frontiers in Oncology|June 19, 2026
Direct comparison of efficacy of combining ivermectin versus five first-line chemotherapy drugs with recombinant methioninase against colon-cancer cellsJinsoo Kim, Qinghong Han, Shukuan Li, et al.
Anticancer Research|June 27, 2025
The Conditions of Non-rescuability of Methioninase-treated Cancer Cells by Methionine Replenishment: The Point of No ReturnByung Mo Kang, Qinghong Han, Shukuan Li, et al.
Cell Cycle (Georgetown, Tex.)|May 7, 2016
Tumor-specific cell-cycle decoy by Salmonella typhimurium A1-R combined with tumor-selective cell-cycle trap by methioninase overcome tumor intrinsic chemoresistance as visualized by FUCCI imagingShuya Yano, Kiyoto Takehara, Ming Zhao, et al.
Methods in Molecular Biology (Clifton, N.J.)|February 7, 2019
Development of Recombinant Methioninase for Cancer TreatmentRobert M Hoffman, Yuying Tan, Shukuan Li, et al.
Anticancer Research|January 30, 2026
Lack of Cancer Specificity of Methionine Adenosyltransferase 2A (MAT2A) Inhibitor AG-270 in Combination With Recombinant Methioninase <i>In Vitro</i>Jinsoo Kim, Qinghong Han, Shukuan Li, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 13, 2005
Tumor-targeting bacterial therapy with amino acid auxotrophs of GFP-expressing Salmonella typhimuriumMing Zhao, Meng Yang, Xiao-Ming Li, et al.
Anticancer Research|December 30, 2025
Effect of Recombinant Methioninase Dose and Timing on the Selective and Precise Elimination of Cancer Cells from Co-Cultured Normal Cells and on Methionine-dependent Rescue of Cancer CellsJinsoo Kim, Qinghong Han, Shukuan Li, et al.
Anticancer Research|October 28, 2025
Simultaneous Targeting of Multiple Hallmarks of Cancer With Recombinant Methioninase, Rapamycin and Chloroquine Is Specific and Synergistic to MiaPaCa-2 Pancreatic-Cancer Cells in Contrast to Hs-27 Normal FibroblastsJinsoo Kim, Qinghong Han, Shukuan Li, et al.
Pageof 6